
GlaxoSmithKline To End Payment To Docs Who Promote Its Drugs
GlaxoSmithKline has announced that it will no longer pay doctors to act as spokespeople for its drugs, citing concerns about conflicts of interest.
GlaxoSmithKline has announced that it will no longer pay doctors to act as spokespeople for its drugs, citing concerns about conflicts of interest.
Banking experts have reported that force-placing insurance became common throughout the U.S. banking industry.
The card details of around 40 million customers have been compromised, Target has announced, in a major security breach at the nationwide store.
The latest news on the litigation involving Takeda Pharmaceutical's product Actos.
Jansseen Pharmaceutical Inc. is brought to court for allegedly keeping patients in the dark about the safety of its' drug, Risperdal.
A new lawsuit claims that some Electrolux refrigerators contain a defect that renders the ice maker useless.
Flyers season ticket holders in a class action lawsuit have reached a settlement worth more than $1 million.
A new study's focus on transvaginal mesh exposes some positive statistics for patients.
Pradaxa seems to have lost some crucial folders that could have better warned those taking the medication.
Research shows that J&J's anti-psychotic drug, Risperdal, may not be what it claims to be.